Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

In the last two decades, second-generation antipsychotics (SGAs) were more frequently used than typical antipsychotics for treating both psychotic and nonpsychotic psychiatric disorders in both children and adolescents, because of their lower risk of adverse neurological effects, that is, extrapyram...

Descripción completa

Detalles Bibliográficos
Autores principales: Porfirio, Maria-Cristina, Gomes de Almeida, Juliana Paula, Stornelli, Maddalena, Giovinazzo, Silvia, Purper-Ouakil, Diane, Masi, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560235/
https://www.ncbi.nlm.nih.gov/pubmed/28860773
http://dx.doi.org/10.2147/NDT.S127564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560235/
https://www.ncbi.nlm.nih.gov/pubmed/28860773
http://dx.doi.org/10.2147/NDT.S127564

Ejemplares similares